Login Register Cart 0
Generic placeholder image

Current Reviews in Clinical and Experimental Pharmacology

Editor-in-Chief

ISSN (Print): 2772-4328
ISSN (Online): 2772-4336

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Clinical Trial

Survival Benefits of N-Acetylcysteine in Rodenticide Poisoning: Retrospective Evidence from an Indian Tertiary Care Setting

Author(s): Karen Mark, Shabnam Hyder, Muhammed Rashid, Viji P. Chandran, Shubha Seshadri, Sneha Seshadri, Sreedharan Nair and Girish Thunga*

Volume 16, Issue 2, 2021

Published on: 13 May, 2020

Page: [201 - 208] Pages: 8

DOI: 10.2174/1574884715666200513090634

Price: $65

Abstract

Rationale & Objective: Rodenticide poisoning, either accidental or intentional, is very common in rural India. The absence of a definite antidote made it a major concern with a high mortality rate. Therefore, this study aimed to assess the effectiveness of N-Acetyl Cysteine (NAC) in rodenticide poisoning as there are recent positive shreds of evidence on it.

Methodology: A retrospective study was conducted in a tertiary care teaching hospital on patients admitted with rodenticide poisoning during a period of 2012-2017. The Fischer’s exact test and relative risk were measured to analyze the outcome of treatment and risk factors, respectively.

Results: A total of 229 patients were enrolled in the study with a mean age of 30.04 ± 15.67 years. The suicidal attack was the major (86.0%) reason for poison consumption. The survival rate was significantly (p ≤ 0.03) higher in the NAC treatment group compared to the non-NAC group. Moreover, the majority (93.4%) of participants did not experience any adverse effects. The mean oral loading dose and maintenance dose was 7580.95 ± 2204.29 mg and 3694.53 ± 2322.58 mg, respectively. Yellow Phosphorus poisoning (Relative Risk [RR] 2.888 (1.179-7.079); p=0.020) and Time lag of ≥ 24 hours (RR 3.479 (1.137-10.645); p=0.029) were the significant risk factors for mortality.

Conclusion: NAC is shown to have a significant survival benefit with a good safety profile among rodenticide poisoners. Further adequately powered prospective researches with more emphasis on dosing parameters are warranted for better quantification in different settings and for clinical implementation.

Keywords: Rodenticides, poisons, N-acetylcysteine, toxicology, antidotes, efficacy.

« Previous
Graphical Abstract

[1]
Proudfoot AT. Aluminium and zinc phosphide poisoning. Clin Toxicol (Phila) 2009; 47(2): 89-100.
[http://dx.doi.org/10.1080/15563650802520675] [PMID: 19280425]
[2]
Debbarma M, Dasgupta A. Yellow phosphorus induced acute fulminant liver failure. Assam J Intern Med 2017; 7(1): 47-8.
[3]
Mohideen SK, Kumar KS. Should ratol paste be banned? Indian J Crit Care Med 2015; 19(2): 128-9.
[http://dx.doi.org/10.4103/0972-5229.151026] [PMID: 25722560]
[4]
National Pesticide Information Centre. Zinc Phosphide 2010 Available from: http://npic.orst.edu/ingred/zp.html [Accessed 2019 March 12].
[5]
Agarwal A, Robo R, Jain N, Gutch M, Consil S, Kumar S. Oxidative stress determined through the levels of antioxidant enzymes and the effect of N-acetylcysteine in aluminum phosphide poisoning. Indian J Crit Care Med 2014; 18(10): 666-71.
[http://dx.doi.org/10.4103/0972-5229.142176] [PMID: 25316977]
[6]
Mishra AK, Devakiruba NS, Jasmine S, Sathyendra S, Zachariah A, Iyadurai R. Clinical spectrum of yellow phosphorous poisoning in a tertiary care centre in South India: A case series. Trop Doct 2017; 47(3): 245-9.
[http://dx.doi.org/10.1177/0049475516668986] [PMID: 27663491]
[7]
Environmental Protection Agency. RED Facts Zinc Phosphide 1998. Available from: www.epa.gov/oppsrrd/REDs/factsheets/0026fact.pdf [Accessed 2019 April 15].
[8]
Bhat S, Kenchetty KP. N-Acetyl cysteine in the management of rodenticide consumption-life saving? J Clin Diagn Res 2015; 9(1): OC 10-13.
[9]
Chugh SN, Chugh K, Ram S, Malhotra KC. Electrocardiographic abnormalities in aluminium phosphide poisoning with special reference to its incidence, pathogenesis, mortality and histopathology. J Indian Med Assoc 1991; 89(2): 32-5.
[PMID: 2056173]
[10]
Nalabothu M, Monigari N, Acharya R. Clinical profile and outcomes of rodenticide poisoning in tertiary care hospital. Int J Scientific and Res Publications 2015; 5(8): 1-2.
[11]
Lohani SP, Rajendra BC, Bidur O. An Epidemiological Study on Acute Zinc phosphide poisoning in Nepal. J Nepal Health Res Counc 2002; 1: 13-6.
[12]
Eddleston M, Phillips MR. Self-poisoning with pesticides. BMJ 2004; 328(7430): 42-4.
[http://dx.doi.org/10.1136/bmj.328.7430.42] [PMID: 14703547]
[13]
Singh RB, Singh RG, Singh U. Hypermagnesemia following aluminum phosphide poisoning. Int J Clin Pharmacol Ther Toxicol 1991; 29(2): 82-5.
[PMID: 2026469]
[14]
Goel A, Aggarwal P. Pesticide poisoning. Natl Med J India 2007; 20(4): 182-91.
[PMID: 18085124]
[15]
Dipalma JR. Human toxicity from rat poisons. Am Fam Physician 1981; 24(4): 186-9.
[PMID: 7282509]
[16]
Patial RK, Bansal SK, Kashyap S, Sharma AK, Sharma B. Hypoglycaemia following zinc phosphide poisoning. J Assoc Physicians India 1990; 38(4): 306-7.
[PMID: 2391337]
[17]
McCarron MM, Gaddis GP, Trotter AT. Acute yellow phosphorus poisoning from pesticide pastes. Clin Toxicol 1981; 18(6): 693-711.
[http://dx.doi.org/10.3109/15563658108990295] [PMID: 7273676]
[18]
Simon FA, Pickering LK. Acute yellow phosphorus poisoning. “Smoking stool syndrome. JAMA 1976; 235(13): 1343-4.
[http://dx.doi.org/10.1001/jama.1976.03260390029021] [PMID: 946251]
[19]
Tomlin C. The Pesticide ManualA World Compendium. 10th ed. Thornton Heath, UK: British Crop Protection Council 1994.
[20]
Chugh SN, Kolley T, Kakkar R, Chugh K, Sharma A. A critical evaluation of anti-peroxidant effect of intravenous magnesium in acute aluminium phosphide poisoning. Magnes Res 1997; 10(3): 225-30.
[PMID: 9483483]
[21]
Kafeel SI, Chandrasekaran VP, Eswaran VP. Role of N- Acetyl cysteine in outcome of patients with yellow phosphorus poisoning-An observational study. Nat J Emerg Med 2012; 1(1): 35-40.
[22]
Mumtaz K, Azam Z, Hamid S, et al. Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009; 3(4): 563-70.
[http://dx.doi.org/10.1007/s12072-009-9151-0] [PMID: 19727985]
[23]
Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli-Vergani G, Dhawan A. Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl 2008; 14(1): 25-30.
[http://dx.doi.org/10.1002/lt.21246] [PMID: 18161828]
[24]
Juhi S, Singh TS, Singh JM, Muhammed R, Manik C, Kumar TR. Ataxia, manifestation of phenytoin toxicity: a case report. J Young Pharm 2019; 11(1): 112.
[http://dx.doi.org/10.5530/jyp.2019.11.24]
[25]
Rashid M, Kashyap A, Undela K. Valproic acid and Stevens-Johnson syndrome: A systematic review of descriptive studies. Int J Dermatol 2019; 58(9): 1014-22.
[http://dx.doi.org/10.1111/ijd.14411] [PMID: 30809807]

Rights & Permissions Print Cite
Article Metrics
25
1
© 2024 Bentham Science Publishers | Privacy Policy